# OptoMedic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/optomedic

- Industry: Medical Devices & Equipment
- Headquarters: Foshan, China
- Website: www.optomedic.com
- Total disclosed funding: $33M
- Latest round: Series D (Jul 15, 2021)
- Investors on record: 9

## About

Founded in 2013, and based in Foshan, China, OptoMedic is a medical technology company that focuses on the research and development of optical medical devices. It has marketing centers in Beijing, Shanghai, and Guangzhou, and product development and industrialization centers in Suzhou and Changsha. The company has acquired FDA and CE certifications, and NMPA incense on 4k fluorescence endoscopy systems. In July 2023, OptoMedic raised over CNY 200 million in pre-IPO funding. In December 2023, the company closed a strategic investment.

The company engages in the development of medical endoscopes. Its main products include FINE P3 series high-definition fluorescent navigation endoscopy system, 2100 series high-definition fluorescent navigation endoscopy system and 1000P series photodynamic diagnostic endoscopy system, etc. The FINE P3 series of high-definition fluorescence navigation endoscopy system can track the lymphatic system in real time, observe tissue blood perfusion and accurately locate the tumor boundary.

OptoMedic plans to conduct overseas patent and international registration and certification layout to accelerate the launching of products in overseas.

## Funding rounds

- Series D, Jul 15, 2021, $15M — Primavera Capital Group, China Merchants Capital
- Series C, Apr 9, 2020, $14M — Lotus Lake Capital, Morale Capital
- Series B, May 17, 2018 — Kaiwu Capital, THG Ventures, Guangdong Xiyu Investment & Management
- Series A, Jun 24, 2016, $3M — Fortune Capital, THG Ventures, Insight Capital
- Angel, Apr 11, 2016 — Fortune Capital, THG Ventures

## Investors

- Fortune Capital — Angel, Series A
- THG Ventures (https://capitalatlas.ai/funds/thg-ventures) — Angel, Series A, Series B
- Insight Capital — Series A
- Kaiwu Capital (https://capitalatlas.ai/funds/kaiwu-capital) — Series B
- Guangdong Xiyu Investment & Management — Series B
- Lotus Lake Capital (https://capitalatlas.ai/funds/lotus-lake-capital) — Series C
- Morale Capital (https://capitalatlas.ai/funds/morale-capital) — Series C
- Primavera Capital Group (https://capitalatlas.ai/funds/primavera-capital-group) — Series D
- China Merchants Capital (https://capitalatlas.ai/funds/china-merchants-capital) — Series D